explore -WSS

explore

author：explore 2025-09-27 13:10:50 - browse：5644

WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： How to make Best Hospitals ratings actually useful for patients

WSS

FDA panel gives mixed vote on blood pressure devices

Why age limits for politicians are a terrible idea

NYU Langone launches private ChatGPT for its health care data

2024 GOP presidential candidates spar over abortion in debate

How Long Island became the ‘eugenics capital of the world’

What to expect at HLTH 2023, the health care industry conference

focus

explore

focus

Continuity nursing helped my family in our darkest PICU moments

FDA panel signals lack of confidence in Amgen cancer drug data

What does generative AI mean for health care? We asked experts

Chan Zuckerberg Biohub Chicago to focus on inflammation

Walensky prepares to leave CDC — and Congress — behind

Chemotherapy drug shortage eases slightly but still widespread

Medicare proposal to cover medical devices draws a mixed reaction

Colorectal cancer study finds potential in overlooked immune cell

Sports medicine is finally prioritizing gender equality

3 questions for the future of Biden's cancer moonshot

knowledge

AI can decode, harness the power of the humane immune system

In science, is the line between industry and academia shifting?

FDA panel gives mixed vote on blood pressure devices

How a symptom of dementia informs our understanding of creativity

Complete sequence of Y chromosome published for first time

Senate panel eyes new effort on drug shortages

explore

focus

explore

knowledge